Novo's Suit Over Compounded Weight-Loss Drug Is Tossed
A Florida federal judge has issued an order dismissing Novo Nordisk Inc.'s suit against a Florida independent pharmacy for selling compounded semaglutide, a peptide also found in Ozempic, Novo's blockbuster diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article